康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09926 康方生物

休市中 07-17 16:08:11

88.350

-13.450

-13.21%

最高100.100	最低87.500	成交量2,363万
今开99.700	昨收101.800	日振幅12.38%
总市值813.70亿	流通市值813.70亿	总股本9.21亿
成交额21.48亿	换手率2.57%	流通股本9.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"康方生物","latestPrice":88.35,"timestamp":1784275691010,"preClose":101.8,"halted":0,"volume":23626337,"delay":0,"changeRate":-0.13212180746561888,"floatShares":921000000,"shares":921000000,"eps":-1.4263299168215144,"marketStatus":"休市中","change":-13.45,"latestTime":"07-17 16:08:11","open":99.7,"high":100.1,"low":87.5,"amount":2147511001,"amplitude":0.123772,"askPrice":88.35,"askSize":2000,"bidPrice":87.9,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-1.4263299168215144,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":7,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":101.8,"openAndCloseTimeList":[[1784251800000,1784260800000],[1784264400000,1784275200000]],"volumeRatio":2.1225237905190513,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"AKS.HK","impliedVol":0.7123,"impliedVolPercentile":0.8917},"requestUrl":"/m/hq/s/09926","defaultTab":"news","newsList":[{"id":"1187161354","title":"异动解读｜康方生物盘中下跌3.63%，报92.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187161354","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187161354?lang=zh_cn&edition=full","pubTime":"2026-07-17 09:53","pubTimestamp":1784253209,"startTime":"0","endTime":"0","summary":"7月17日，康方生物盘中下跌3.63%，报92.6港元/股，成交额4.23亿港元。康方生物所在的生物科技行业中，板块整体表现偏弱，个股中，三生制药跌6.87%，荣昌生物跌6.82%，科伦博泰生物跌4.80%，信达生物跌2.44%，百济神州跌1.99%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810439","title":"港股早盘高开高走 恒指半日涨1.46% 创新药、猪肉概念强势","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810439","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651810439?lang=zh_cn&edition=full","pubTime":"2026-07-15 12:11","pubTimestamp":1784088667,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股早盘高开高走，三大股指均升逾1%。截至午间收盘，恒生指数上涨1.46%；国企指数涨1.16%；恒生科技指数涨1.39%。猪价底部大概率已现，预计周期临近上行。预计2026年半年度归属于上市公司股东的扣除非经常性损益的净利润约为人民币20.00亿元到人民币26.00亿元，与上年同期相比，将增加人民币18.62亿元到人民币24.62亿元，同比增长1349%到1784%。MiniMax盘中反复拉升，午间收涨14.96%。港股将受益于中国内地强劲而有韧性的经济表现，建议超配H股。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985921","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3063872942.SGD","LU0823426480.USD","LU2476274308.USD","LU2097828805.USD","LU1226287875.USD","IE0008368742.USD","LU0348735423.USD","BK1515","LU0320764599.SGD","SG9999001226.SGD","LU0516422952.EUR","LU0611395673.USD","IE00B031HY20.USD","LU1328277881.USD","LU2399975544.HKD","688981","LU0871576103.HKD","LU0456846285.SGD","LU0572944931.SGD","00100","BK1574","LU0502904849.HKD","LU1969619763.USD","BK1610","LU1282651048.USD","02419","LU0287142896.SGD","LU2257852520.SGD","LU1634259391.SGD","LU1719994722.HKD","LU0293314216.USD","01177","SG9999012736.USD","IE00B543WZ88.USD","LU0819121731.USD","LU0211977185.USD","83115","LU1794554557.SGD","LU0516423174.USD","LU0634319403.HKD","LU1226287529.USD","LU0039217434.USD","LU0348805143.USD","LU1808992512.USD","LU1807302812.USD","IE0008369823.USD","LU0072462343.USD","09115","IE0032431581.USD","SG9999003461.SGD","LU0359202008.SGD","IE00BWDBJ730.SGD","LU0348783662.USD","01928","02269","LU0307460666.USD","LU0865486749.SGD","LU1785774172.SGD","LU0359201885.HKD","02833","LU0821914370.USD","IE00BZ08YS42.EUR","BK1523","LU1152091168.USD","SG9999002562.SGD","LU1051768304.USD","LU2293587155.HKD","SG9999014674.SGD","LU0456827905.SGD","LU0640798160.USD","00857","02359","BK1584","IE00B0JY6N72.USD","LU0348783233.USD","LU0588545730.USD","LU1497734951.SGD","LU1282651121.HKD","LU2039709279.SGD","02714","LU0196878994.USD","BK1550","LU0048597586.USD","LU0516423091.SGD","LU0067412154.USD","LU1522347837.USD","02800","LU2488822045.USD","LU0348825331.USD","LU2125910500.SGD","LU1188198961.HKD","BK1117","BK1607","LU1226288170.HKD","SG9999001093.SGD","LU2097828631.EUR","LU0181495838.USD","BK1549","LU1152091754.HKD","002714","LU0463099449.HKD","WXXWY","06990","LU0856984785.SGD","LU0163747925.USD","LU0862451753.SGD","LU0516422366.SGD","SGXZ62798434.SGD","00386","BK1237","IE00BPRC5H50.USD","82800","01801","SBHMY","SG9999012710.SGD","SGXZ86797644.SGD","LU1497733631.SGD","03037","LU1242518857.USD","HK0000286598.CNH","LU0173614495.USD","LU1675838814.USD","LU0251144936.SGD","LU0052750758.USD","LU1720050803.USD","BK1603","IE00BQJZWZ67.USD","01610","BK1163","LU1226287792.SGD","LU0051755006.USD","LU0326950275.SGD","LU1048596156.SGD","SG9999012744.USD","LU0169518387.USD","SG9999012728.SGD","BK1141","LU0417516902.SGD","07500","LU0972618739.USD","LU1242518931.SGD","LU0531971595.HKD","601869","BK1226","LU1211504680.USD","LU1251922891.USD","SG9999006597.SGD","LU0823426308.USD","513600","BK1149","BK1562","BK1614","LU0315178854.USD","IE00B19Z5X02.USD","IE00BZ08YR35.GBP","LU0651946864.USD","LU2097828474.EUR","LU0327786744.USD","LU1770034418.SGD","03419","LU1951186391.HKD","LU1993786604.SGD","LU2045819591.USD","LU2097828557.USD","LU1303224171.USD","00981","LU0405327494.USD","601857","LU0441854154.USD","LU1023057109.AUD","LU0315179316.USD","02268","LU0405327148.USD","LU1515016050.SGD","LU0043850808.USD","LU0890818403.SGD","LU2242644610.SGD","LU2097828714.EUR","BK1583","01093","LU0164865239.USD","07300","LU0469268626.HKD","LU1497733557.USD","LU1960683339.HKD","LU0501845795.SGD","IE00BZ08YT58.USD","MCHmain","BK1526","IE00B5MMRT66.SGD","601628","HHImain","07200","KURE","LU1008478684.HKD","LU1046422090.SGD","LU1226288253.USD","BK1161","LU1961090484.USD","603259","LU0417516571.SGD","LU0244354667.USD","BK1191","LU0588545490.SGD","LU0561508036.HKD","LU0072913022.USD","LU1831875114.USD","600028","LU1813983027.USD","LU0828237940.HKD","LU1634259557.SGD","01477","LU2778985437.USD","SG9999004220.SGD","HSTECH","LU1688375341.USD","SG9999002463.SGD","03115","LU0140636845.USD","LU0862451837.USD","BK1184","BK1528","BK1576","LU0979878070.USD","LU2328871848.SGD","BK1589","LU1051769294.HKD","BK1172","09926","LU1048588211.SGD","LU1115378108.SGD","LU0228367735.SGD","LU0314109678.HKD","LU0417516738.SGD","LU0516422440.USD","LU0540923850.HKD","LU0651947912.USD","LU1224444064.USD","LU0588546209.SGD","LU0880133367.SGD","HK0000165453.HKD","LU0348784397.USD","LU0348827113.USD","LU0348766576.USD","06869","BK1506","SCHYY","HSI","LU0348767384.USD","LU0359201612.USD","LU0588545904.SGD","LU0675040207.SGD","LU0708995583.HKD","LU1880383366.USD","BK1521","LU0455707207.USD","02628","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651291435","title":"创新药概念全线扬升 科伦博泰生物(06990)涨逾11% 机构指创新药企迎业绩兑现窗口","url":"https://stock-news.laohu8.com/highlight/detail?id=2651291435","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651291435?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:07","pubTimestamp":1784084836,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念盘中全线扬升，截至发稿，欧康维视生物-B 涨13.35%，科伦博泰生物涨11.20%，康方生物涨8.82%，信达生物涨8.72%，三生制药涨8.11%，康诺亚-B涨7.62%，药明合联涨7.52%，荣昌生物涨7.09%，乐普生物涨6.87%，亚盛医药涨6.26%。该机构持续看好国内创新药出海β向上可持续性，提示投资者关注2027年起众多前期已达成BD的分子将在海外开启商业化新周期所带来的投资机会。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985914","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","01477","LU0502904849.HKD","BK1191","IBBQ","LU0540923850.HKD","LU2476274308.USD","LU2097828557.USD","BK1593","01801","LU2097828714.EUR","02268","LU2097828631.EUR","LU2328871848.SGD","LU2097828805.USD","09995","LU0561508036.HKD","LU0348825331.USD","06855","LU0455707207.USD","LU2399975544.HKD","BK1587","KURE","LU0348827113.USD","LU2097828474.EUR","02157","06990","LU0348767384.USD","IE00B543WZ88.USD","MEDX","LU1961090484.USD","BK1161","BK1574","IE00BPRC5H50.USD","09926","02162","159992","LU0417516571.SGD","LU0634319403.HKD","LU0417516738.SGD","06978","LU0348784397.USD","LU1720050803.USD","LU2778985437.USD","SG9999014674.SGD","BK1589","BK1583","BK1141","LU0417516902.SGD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191702127","title":"异动解读｜康方生物盘中上涨3.86%，与美国顶级癌症中心达成合作推进卡度尼利国际临床","url":"https://stock-news.laohu8.com/highlight/detail?id=1191702127","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191702127?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:41","pubTimestamp":1784079679,"startTime":"0","endTime":"0","summary":"7月15日，康方生物盘中上涨3.86%，报99.9港元/股，成交额1.49亿港元。消息面上，康方生物于7月14日宣布与美国纪念斯隆凯特琳癌症中心达成合作，携手推进全球首创PD-1/CTLA-4双抗卡度尼利联合方案用于局部晚期可切除胃癌围手术期治疗的II期临床研究，目前该研究已在美国入组患者。该研究由国际著名胃肠道肿瘤专家Yelena Janjigian博士领衔，将为后续国际多中心III期研究提供临床证据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199454880","title":"PD-1/CTLA-4双抗卡度尼利联合疗法在美国启动胃癌围手术期治疗II期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1199454880","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199454880?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:19","pubTimestamp":1784017155,"startTime":"0","endTime":"0","summary":"一项针对卡度尼利（一种PD-1/CTLA-4双特异性抗体）联合疗法的II期临床试验，已在美国启动，旨在评估其用于胃癌患者围手术期治疗的效果。该试验标志着相关疗法在胃癌新辅助及辅助治疗领域的探索进入新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0348735423.USD","LU2399975544.HKD","LU1794554557.SGD","LU0348827113.USD","IE00B543WZ88.USD","LU2476274720.SGD","LU0348825331.USD","LU0634319403.HKD","LU0561508036.HKD","KURE","LU0417516738.SGD","LU2476274308.USD","LU2488822045.USD","LU2778985437.USD","BK1574","LU0348766576.USD","LU0540923850.HKD","IE00BPRC5H50.USD","LU0417516571.SGD","LU0348784397.USD","BK1161","LU0417516902.SGD","LU1720050803.USD","LU0348783233.USD","LU1961090484.USD","09926","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651991128","title":"【券商聚焦】中信证券：新基药目录有望加速创新药基层落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2651991128","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651991128?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:57","pubTimestamp":1783990650,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指，《2026年版国家基本药物目录》于7月9日正式发布，将于9月1日起实施。该机构认为，本次新版基药目录新增药物均已属于医保药品，随着基药与医保的深度协同联动，有望极大加速创新药的基层落地，医保控费与创新回报形成良性循环。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985769","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185","06160","LU0359201612.USD","06978","HK0000165453.HKD","LU0823426480.USD","159992","LU2488822045.USD","IE0008368742.USD","09995","KCE","LU1226287792.SGD","600030","LU1242518931.SGD","01093","02269","LU0051755006.USD","BK1161","LU1152091168.USD","KURE","IBBQ","LU1226288253.USD","09688","LU2039709279.SGD","SG9999002463.SGD","LU0572944931.SGD","LU0405327494.USD","LU2476274720.SGD","01877","LU1960683339.HKD","MEDX","LU0417516902.SGD","02616","09926","LU0588546209.SGD","BK1610","LU0043850808.USD","LU1328277881.USD","02142","LU0979878070.USD","LU1961090484.USD","LU2328871848.SGD","IE00BPRC5H50.USD","LU1997244956.HKD","01801","LU0314109678.HKD","06030","LU0327786744.USD","01177","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144404262","title":"异动解读｜康方生物盘中下跌3.08%，报94.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144404262","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144404262?lang=zh_cn&edition=full","pubTime":"2026-07-13 11:03","pubTimestamp":1783911812,"startTime":"0","endTime":"0","summary":"7月13日，康方生物盘中下跌3.08%，报94.25港元/股，成交额3.33亿港元。康方生物所在的生物科技行业中，板块整体表现偏弱，个股中，科伦博泰生物跌4.55%，三生制药跌2.16%，信达生物跌1.62%，百济神州跌0.11%，派格生物医药-B涨3.65%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651568164","title":"【券商聚焦】中信建投：创新药企仍是高增长主线、BD交易持续催化业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2651568164","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651568164?lang=zh_cn&edition=full","pubTime":"2026-07-13 08:53","pubTimestamp":1783903985,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指出，1）制药产业链：创新药企仍是高增长主线，BD交易持续催化业绩。BD授权收入成为多家公司中期业绩关键变量。上游供应链受益于国产替代及下游需求恢复，Q2增速普遍提升，利润端弹性显著。建议关注Q2高增长公司的配置机会。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985645","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185","LU0348784397.USD","159992","IE00B5MMRT66.SGD","BD","09926","LU0348735423.USD","BK1588","BK1161","01177","LU2097828474.EUR","09688","IE00B0JY6N72.USD","02142","LU1993786604.SGD","LU0456846285.SGD","01093","LU2097828631.EUR","IE0008369823.USD","KURE","IE0008368742.USD","601066","LU2242644610.SGD","LU0359201612.USD","MEDX","LU0516422366.SGD","BK1515","KCE","LU1688375341.USD","LU1961090484.USD","01801","LU1813983027.USD","01877","LU1807302812.USD","06978","02616","LU0067412154.USD","LU0501845795.SGD","LU1226288170.HKD","LU0455707207.USD","09995","LU0348825331.USD","LU2488822045.USD","06160","02269","LU0051755006.USD","LU1960683339.HKD","IBBQ","LU0359202008.SGD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142945971","title":"异动解读｜康方生物盘中上涨4.38%，创新药支付改革持续催化叠加板块联动走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1142945971","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142945971?lang=zh_cn&edition=full","pubTime":"2026-07-10 10:06","pubTimestamp":1783649215,"startTime":"0","endTime":"0","summary":"7月10日，康方生物盘中上涨4.38%，报98.8港元/股，成交额2.46亿港元。消息面上，创新药支付改革持续催化。国家医保局此前公布医保目录初审结果，\"医保+商保\"双目录谈判进入实质推进阶段，叠加预申报机制、8年价格保护等新机制同步落地，为创新药商业化提供稳定政策预期。康方生物5款自研新药全部适应症已纳入国家医保，新药奇佑康完成全国首批发货，有望加速市场放量。板块方面，生物科技行业整体走强，荣昌生物涨5.37%、信达生物涨3.71%、百济神州涨1.98%，板块联动效应明显。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142522962","title":"异动解读｜康方生物盘中上涨3.32%，创新药支付改革持续催化叠加板块联动走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1142522962","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142522962?lang=zh_cn&edition=full","pubTime":"2026-07-09 09:59","pubTimestamp":1783562363,"startTime":"0","endTime":"0","summary":"7月9日，康方生物盘中上涨3.32%，报99.7港元/股，成交额2.14亿港元。消息面上，创新药支付改革持续催化。国家医保局此前公布医保目录初审结果，\"医保+商保\"双目录谈判进入实质推进阶段，叠加预申报机制、8年价格保护等新机制同步落地，为创新药商业化提供稳定政策预期。康方生物5款自研新药全部适应症已纳入国家医保，新药奇佑康完成全国首批发货，有望加速市场放量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649954218","title":"创新药板块走低 科伦博泰生物(06990)跌7.67% 当前板块仍处估值修复行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2649954218","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649954218?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:08","pubTimestamp":1783480087,"startTime":"0","endTime":"0","summary":"有研究指，创新药板块年内曾两轮短期反弹，本轮行情依托政策组合、高含金量海外交易、机构持续加仓三大不同支撑，但机构表示当前仅为估值修复行情，基本面全面反转仍需中期、三季度财报验证，后续走势重点跟踪企业盈利兑现与CGT正式政策落地进度。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985359","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2242644610.SGD","01672","06955","BK1141","IE00B0JY6N72.USD","01530","00460","LU0196878994.USD","LU1046422090.SGD","LU0140636845.USD","SG9999014674.SGD","06855","BK1521","02186","LU0320764599.SGD","CZA","LU0588546209.SGD","159992","BK1515","BK1600","09926","LU0051755006.USD","LU0979878070.USD","02269","LU0516423091.SGD","LU0417516571.SGD","LU0572944931.SGD","LU0456846285.SGD","BK1583","LU0326950275.SGD","LU0348784397.USD","SG9999002463.SGD","LU1880383366.USD","MEDX","02268","LU0348783233.USD","REVS","LU0516422440.USD","IBBQ","KURE","LU2476274308.USD","02359","LU0819121731.USD","06978","LU3063872942.SGD","01477","06990","01952","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145436447","title":"异动解读｜康方生物盘中上涨3.12%，创新药支付改革持续催化叠加前日回调后反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1145436447","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145436447?lang=zh_cn&edition=full","pubTime":"2026-07-08 09:48","pubTimestamp":1783475336,"startTime":"0","endTime":"0","summary":"7月8日，康方生物盘中上涨3.12%，报99.55港元/股，成交额1.79亿港元。前一交易日该股随板块整体走弱下跌3.24%，今日呈现技术性反弹。消息面上，创新药支付改革持续催化。康方生物5款自研新药全部适应症已纳入国家医保，新药奇佑康完成全国首批发货，有望加速市场放量。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193970125","title":"异动解读｜康方生物盘中下跌3.24%，报98.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193970125","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193970125?lang=zh_cn&edition=full","pubTime":"2026-07-07 13:08","pubTimestamp":1783400880,"startTime":"0","endTime":"0","summary":"7月7日，康方生物盘中下跌3.24%，报98.6港元/股，成交额6.31亿港元。康方生物所在的生物科技行业中，板块整体走弱，个股中，荣昌生物跌4.78%，信达生物跌2.38%，百济神州跌2.15%，康诺亚-B跌1.67%，科伦博泰生物跌1.24%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120886075","title":"异动解读｜康方生物盘中上涨3.32%，创新药支付改革持续催化叠加板块联动走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1120886075","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120886075?lang=zh_cn&edition=full","pubTime":"2026-07-06 09:38","pubTimestamp":1783301927,"startTime":"0","endTime":"0","summary":"7月6日，康方生物盘中上涨3.32%，报104.4港元，成交额2.11亿港元。康方生物5款自研新药全部适应症已纳入国家医保，新药奇佑康完成全国首批发货，有望加速市场放量。同板块荣昌生物涨3.82%、科伦博泰生物涨3.11%、三生制药涨2.92%，行业beta共振延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187316635","title":"异动解读｜康方生物盘中上涨4.8%，创新药支付改革持续催化叠加生物科技板块集体走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1187316635","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187316635?lang=zh_cn&edition=full","pubTime":"2026-07-03 09:35","pubTimestamp":1783042511,"startTime":"0","endTime":"0","summary":"7月3日，康方生物盘中上涨4.8%，报100.5港元，成交额1.87亿港元。公司5款自研新药全部适应症已纳入国家医保，叠加新药奇佑康完成全国首批发货，有望加速市场放量。同板块三生制药涨6.78%、荣昌生物涨6.18%、百济神州涨4.75%，行业beta共振助推反弹。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648634520","title":"【券商聚焦】中信建投：看好相关创新药及制药企业医保准入与商保增量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2648634520","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648634520?lang=zh_cn&edition=full","pubTime":"2026-07-03 08:36","pubTimestamp":1783038993,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究指，2026年6月29日，国家医保局公示通过2026年基本医保目录及商保创新药目录调整初步形式审查的药品名单及相关信息。叠加今年首次引入的“预申报”机制，本次结果充分体现了医保目录调整对创新药的持续倾斜，看好相关创新药及制药企业的医保准入与商保增量空间。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985028","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","LU1961090484.USD","01177","LU0067412154.USD","LU2778985437.USD","LU1969619763.USD","LU0348766576.USD","IE00B031HY20.USD","LU0417516902.SGD","LU2476274308.USD","09926","LU2097828805.USD","01093","01801","IE00B5MMRT66.SGD","01877","159992","LU1688375341.USD","LU0456846285.SGD","LU0315179316.USD","06160","LU2097828714.EUR","LU0501845795.SGD","LU1226287792.SGD","SG9999004220.SGD","LU2488822045.USD","601066","LU0856984785.SGD","LU2097828631.EUR","01477","BK1589","02269","HK0000165453.HKD","IE0008369823.USD","LU1242518931.SGD","LU0516422366.SGD","LU2476274720.SGD","LU1226287875.USD","LU0979878070.USD","LU2039709279.SGD","LU3063872942.SGD","09688","LU0043850808.USD","LU0502904849.HKD","LU0072913022.USD","06185","02616","LU0417516738.SGD","06978","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173431390","title":"康方生物6月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1173431390","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173431390?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:09","pubTimestamp":1782983395,"startTime":"0","endTime":"0","summary":"2026年7月2日，康方生物科技（开曼）有限公司发布截至2026年6月30日的股份变动月报。公告显示，公司法定股本及已发行股份总数在本期维持不变。公司法定注册股本为5,000,000,000股普通股，每股面值0.00001美元，截至报告期末仍为50,000美元，未发生变动。报告期内，公司股本结构总体保持稳定，未有新增发行及回购活动。公告由董事夏瑜签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648575107","title":"港股直击 | 创新药概念股继续走高，创新药支付改革加速，药企有望持续步入业绩收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2648575107","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648575107?lang=zh_cn&edition=full","pubTime":"2026-07-02 11:36","pubTimestamp":1782963369,"startTime":"0","endTime":"0","summary":"7月2日，创新药概念股继续走高，先声药业、三生制药涨超8%；信达生物涨超7%；康方生物涨近7%。消息面上，国家医保局公布2026年医保目录初审结果，共有557个药品通过医保目录初审，54个药品通过商保创新药目录初审，意味着“医保+商保”双目录谈判进入实质推进阶段。与此同时，预申报机制、8年价格保护等新机制同步落地，进一步完善创新药支付体系，为创新药商业化提供更加稳定的政策预期。","market":"hk","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462173.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348825331.USD","LU0417516571.SGD","LU0417516902.SGD","LU2097828631.EUR","LU1961090484.USD","BK1161","VXUS","BK4588","IE00B5MMRT66.SGD","LU2097828557.USD","01801","LU2097828805.USD","BK4585","01530","LU1794554557.SGD","LU0561508036.HKD","BK1574","LU0348766576.USD","LU0348767384.USD","LU0348784397.USD","LU2097828474.EUR","IE00BPRC5H50.USD","BK1589","159992","LU0455707207.USD","LU2328871848.SGD","BK1583","LU2476274720.SGD","LU1969619763.USD","LU0502904849.HKD","LU2778985437.USD","06978","LU2488822045.USD","HK0000165453.HKD","09926","LU0417516738.SGD","LU0348735423.USD","LU2399975544.HKD","LU2097828714.EUR","02096","BK1593","LU1720050803.USD","LU0540923850.HKD","BK1191","LU2242644610.SGD","LU0348783233.USD","LU0348827113.USD","IE00B543WZ88.USD","LU0634319403.HKD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156033454","title":"异动解读｜康方生物盘中上涨6.3%，生物科技板块集体走强叠加前期回调后资金回补","url":"https://stock-news.laohu8.com/highlight/detail?id=1156033454","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156033454?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:31","pubTimestamp":1782955914,"startTime":"0","endTime":"0","summary":"7月2日，康方生物盘中上涨6.3%，报93.75港元，成交额7041.42万港元。公司股价在前一交易日回调约4%后出现反弹，生物科技板块整体走强为个股提供上行动力。此外，公司首席科学官近日披露AI驱动药物研发平台进展，强化长期研发效率预期。同板块三生制药涨10.12%、康诺亚-B涨8.41%、荣昌生物涨5.45%、信达生物涨5.03%，行业beta共振助推反弹。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163976103","title":"异动解读｜康方生物盘中下跌3.06%，前日大涨逾12%后获利回吐叠加生物科技板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1163976103","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163976103?lang=zh_cn&edition=full","pubTime":"2026-06-30 10:08","pubTimestamp":1782785286,"startTime":"0","endTime":"0","summary":"6月30日，康方生物盘中下跌3.06%，报88.85港元，成交额2.73亿港元。公司前一交易日曾大涨近13%，主要受Evaluate全球最具价值管线榜单依沃西登顶及新药奇佑康完成全国首批发货双重利好提振，今日出现技术性回吐。近期公司股价自ASCO数据公布后高点累计回撤超30%，虽有2亿港元回购计划及管理层增持托底，但短期抛压仍未完全消化。同板块百济神州跌2.18%、荣昌生物跌3.39%、药捷安康跌4.4%，生物科技板块整体偏弱，行业beta拖累加剧个股调整压力。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.akesobio.com","stockEarnings":[{"period":"1week","weight":-0.0915},{"period":"1month","weight":0.053},{"period":"3month","weight":-0.4149},{"period":"6month","weight":-0.2698},{"period":"1year","weight":-0.3667},{"period":"ytd","weight":-0.2181}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0103},{"period":"3month","weight":-0.0611},{"period":"6month","weight":-0.085},{"period":"1year","weight":0.0026},{"period":"ytd","weight":-0.0417}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康方生物科技（开曼）有限公司是一家致力于研究、开发、生产及商业化让全球病人可负担的抗体药的投资控股公司。该公司在研项目涵盖肿瘤、自身免疫及代谢性疾病等多个领域。该公司的产品主要包括有用于肿瘤领域的开坦尼（卡度尼利，PD-1/CTLA-4）、依达方（依沃西，PD-1/VEGF）、莱法利（AK117，CD47）、普络西（AK109，VEGFR-2）、安尼可（派安普利，PD-1）、科泰莱（塔戈利单抗，PD-L1）和用于代谢及自免领域的伊喜宁（伊努西单抗，PCSK9）、爱达罗（依若奇单抗，IL-12/IL-23）、古莫奇单抗（AK111，IL-17）。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003338},{"month":2,"riseRate":0.333333,"avgChangeRate":0.019031},{"month":3,"riseRate":0.5,"avgChangeRate":0.006875},{"month":4,"riseRate":0.833333,"avgChangeRate":0.041517},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.021305},{"month":6,"riseRate":0.571429,"avgChangeRate":0.077852},{"month":7,"riseRate":0.571429,"avgChangeRate":0.075801},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007754},{"month":9,"riseRate":0.5,"avgChangeRate":0.036209},{"month":10,"riseRate":0.5,"avgChangeRate":0.046029},{"month":11,"riseRate":1,"avgChangeRate":0.102206},{"month":12,"riseRate":0.333333,"avgChangeRate":0.028279}],"exchange":"SEHK","name":"康方生物","nameEN":"AKESO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康方生物(09926)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康方生物,09926,康方生物股票,康方生物股票老虎,康方生物股票老虎国际,康方生物行情,康方生物股票行情,康方生物股价,康方生物股市,康方生物股票价格,康方生物股票交易,康方生物股票购买,康方生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康方生物(09926)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}